Zydus Cadila

Zydus Cadila’s Covid-19 Vaccine For Children Aged 12-18 May Be Available Soon: Centre

Gujarat-based pharmaceutical company Zydus Cadila is developing a vaccine against the COVID-19 infection in children which may be available soon for children in the age group of 12 to 18…

View Post

India’s Zydus Cadila Seeks Nod For Its 3-Dose, “Needle-Free” Vaccine

India’s Zydus Cadila has sought emergency use approval for its ZyCoV-D three-dose Covid shot that is the “world’s first Plasmid DNA vaccine”. The company said, it is a “needle-free” and…

View Post

Latest News

Zydus Cadila Gets Tentative USFDA Nod To Market Generic Sclerosis Treatment Drug

Drug firm Zydus Cadila has received tentative approval from the US health regulator to market Fingolimod capsules, used in the treatment of multiple sclerosis, in the American market. The company…

View Post

Zydus Cadila Gets USFDA Tentative Nod For Epilepsy Treatment Drug

A tentative approval has been given to Zydus Cadila by the US health regulator to market epilepsy treatment drug called Brivaracetam tablets, informed the company on Monday. Zydus Cadila has…

View Post

Latest News

Zydus Cadila Receives Tentative Approval From USFDA To Market Lung Cancer Drug Osimertinib

Study Shows Potential Survival Benefit of Osimertinib in T790M-Positive NSCLC Patients with Multiple CNS Metastases

View Post

India’s Zydus Cadila Seeks Human Trial Approval For Covid-19 Antibody Cocktail

Amid the shortage of medicines and vaccines in the country that is needed to effectively tackle a devastating second wave of the pandemic, India’s Zydus Cadila seeks regulatory approval for…

View Post

Latest News

Zydus Cadila Launches Ujvira, First Antibody Drug Conjugate (ADC) Breast Cancer Treatment

Zydus Cadila has launched Trastuzumab Emtansine, the first antibody Drug Conjugate (ADC) biosimilar for early and advanced HER2 positive Breast Cancer Patients’ treatment. The drug has been launched under the…

View Post

Menu

Zydus Cadila

Zydus Cadila’s Covid-19 Vaccine For Children Aged 12-18 May Be Available Soon: Centre

India’s Zydus Cadila Seeks Nod For Its 3-Dose, “Needle-Free” Vaccine

Zydus Cadila Gets Tentative USFDA Nod To Market Generic Sclerosis Treatment Drug

Zydus Cadila Gets USFDA Tentative Nod For Epilepsy Treatment Drug

Zydus Cadila Receives Tentative Approval From USFDA To Market Lung Cancer Drug Osimertinib

India’s Zydus Cadila Seeks Human Trial Approval For Covid-19 Antibody Cocktail

Zydus Cadila Launches Ujvira, First Antibody Drug Conjugate (ADC) Breast Cancer Treatment

High Court Slams Doctors for Prioritizing Private Practice Over Public Healthcare

National Cancer Awareness Day 2024: Fatigue, Unexplained Weight Loss, 6 Early Warning Signs of Cancer

Delhi AQI Today: Does Inhaling Toxic Smog Increases Heart Attack Risk?

Hearing Loss Is an Independent Risk Factor for Parkinson’s Disease: Jama Study Reveals

Breastfeeding Linked to Lower Rates of Postpartum Depression: Study Finds

Consuming High Levels of Omega-3, Omega-6 May Keep Cancer at Bay: Study Reveals

Effective Pain Management Approaches to Enhance Quality of Life

Chhatt Songs’ Singer Sharda Sinha Succumbs To Blood Poisoning Complication: Know All About It